The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
Signal Genetics 
General Information
Business: We are an emerging commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. Our mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions. We were founded in January 2010 and became the exclusive licensee in our licensed field to the renowned research on multiple myeloma performed at UAMS in April 2010.
Industry: MEDICAL LABORATORIES
Employees: 14 Founded: 2010
Contact Information
Address: 667 Madison Avenue, 14th Floor, New York, NY 10065, US
Phone: 212-486-0040
Web Address: www.signalgenetics.com
View Prospectus: Signal Genetics
Financial Information
Market Cap: $ 45.5 mil
Revenues: $ 4.3 mil (last 12 months)
Net Income: $ -2.3 mil (last 12 months)
IPO Profile
Symbol: SGNL
Shares (millions): 0.9
Price Range: $10.00 - $10.00
Est.$ Volume $ 8.5 mil
Manager / Joint Managers Aegis Capital Corp
Co Managers -
Expected to Trade 6/18/2014
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.